Tissue/Organ

EnClear bags $10m to start first in-human

We talk exclusively with the Longevity start-up targeting neurodegenerative disease with novel therapeutic filtration (device) technology. Its mission: access and control cerebrospinal fluid to get...

Bioengineering breakthrough for patching broken hearts

Bioengineering team from Trinity College in Dublin develops a prototype patch that does the same job as crucial aspects of heart tissue. One in six men...

J&J enters Longevity market with “Immorbidity” play

A new competition aims to find the next great breakthrough to help us stay active and healthy beyond the age of 100. People are living...

Proteomics and biological age measurement

AgeCurve closes in on first round investment as it builds its team with the support of key opinion leaders in aging research. UK start-up AgeCurve...

“Human-on-a-Chip” OOC to revolutionise preclinical

New system of linked mini-organs heralds a new era of comprehensive drug testing that is faster and more efficient than anything seen before. OOC...

Lab-grown muscle in heart transplant breakthrough

Japanese research team announces world-first. Lab-grown heart muscles created from induced pluripotent stem (iPS) cells successfully transplanted into a human: a new take on...

Aspect Biosystems talks regeneration

Finding out what’s behind the $20m bioprinting start-up. Vancouver-based Aspect Biosystems recently closed a $20 million funding round, making it one of the world’s most...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Aspect Biosystems raises $20m for human bioprinting

Further boost for 3D bio-printing sector as Aspect Biosystems announces a multimillion funding round for advanced therapies. Biotechnology company and pioneer in the 3D printing...

Xenotransplant pigs organs one-step closer

Scientists are moving closer to creating first human transplant organs from pigs. More than 100,000 people are on the organ transplant waiting list in the US...

AI-built “living machine” is world first

Evolved by AI algorithms from frog cells into something not remotely Kermit-like, this living machine is a real leap forward for Longevity. Forget everything you...

Mini livers can be printed within 90 days

A new study suggests mini livers can be successfully printed in the laboratory within 90 days. This could have profound implications for transplant patients...

Supporting research and organ growth. Literally

Manchester BIOGEL to start providing kits for tissue growth as the company scales-up in 2020. Another of the interesting companies we encountered at the 3D...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

Final frontier – 3D bioprinting in space

A strategic partnership between CELLINK and Made in Space promises advances for drug screening and cancer treatments. CELLINK, a Swedish bioprinter manufacturer, has announced a...

University of Minho to spin out bioprinting start-up

Research developments create a company focused on meniscus regeneration; seed funding planned for early 2020. One of the leading speakers at the recent 3D Bioprinting...

The Pentagon and Longevity tech opportunities

A released Pentagon report identifies research in areas with Longevity application - tech is moving fast and makes for intriguing reading. The US Military has...

New hydrogel advances Longevity applications

Hydrogels have been used in everything from contact lenses to babies’ nappies. Now, scientists have made a breakthrough which could pave the way for...

Organoids will attract bigger investment in 2020

Mini organs set for maximum success as new models can be used to individualise cancer therapy. Organoids are three-dimensional bundles of cells grown in culture...

Latest articles

114 year-old cells converted to pluripotent stem cells

AgeX publishes evidence of supercentenarian cellular age reversal: new paper supports hypothesis of no upper age limit for reprogramming cellular aging. This is big...

Placenta blood and personalised Longevity therapies

The placenta is a reservoir of stem cells with minimal ethical concerns. The establishment of placental stem cell biobanks will enable their use in...

Anti-aging drugs in MIT’s 10 Breakthrough Technologies 2020

For the last 20 years MIT Technology Review's Breakthrough Technologies 2020 has been assessing the way we live, work and invest.  Back in 2001, MIT...

Proving the Longevity potential of NAD+

Talking sirtuins, NAD+ and trials with Elysium Health CEO Eric Marcotulli. When it comes to the world of consumer anti-aging supplements, there are few higher-profile...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.